Aptalis Pharmatech, Inc.
11Patents
10Active
11Granted
47Portfolio score
Filing activity: Dec 31, 2002 → Aug 23, 2013 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8771729B2 | Orally administered corticosteroid compositions | Human Necessities | 24 | Active |
| US8747895B2 | Orally disintegrating tablets of atomoxetine | Human Necessities | 15 | Active |
| US8367111B2 | Extended release dosage forms of propranolol hydrochloride | Human Necessities | 14 | Expired |
| US9040086B2 | Timed, sustained release systems for propranolol | Human Necessities | 11 | Active |
| US8137734B2 | Preparation of controlled release skeletal muscle relaxant dosage forms | Human Necessities | 8 | Active |
| US8840925B2 | Orally disintegrating tablet compositions of lamotrigine | Human Necessities | 6 | Active |
| US9089490B2 | Orally disintegrating tablets and methods of manufacture | Human Necessities | 4 | Active |
| US8647656B2 | Orally disintegrating tablet compositions of lamotrigine | Human Necessities | 1 | Active |
| US8133506B2 | Drug delivery systems comprising weakly basic drugs and organic acids | Human Necessities | 0 | Active |
| US8877245B2 | Modified release dosage forms of skeletal muscle relaxants | Emerging Cross-Sectional Technologies | 0 | Active |
| US8962022B2 | Pharmaceutical compositions comprising an active substance from the substituted benzhydrylpiperazine family | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.